AAVogen Inc
Abata Therapeutics
Abcuro Inc
Alzheon Inc
Cleave Therapeutics Inc
Leadiant Biosciences Inc
Milo Biotechnology LLC
Nobelpharma Co Ltd
PhaseBio Pharmaceuticals Inc
Vandria SA
Published | Pages | Publisher | Report code |
---|---|---|---|
Aug 2022 | 104 | Global Markets Direct | ASDR-609029 |
AAVogen Inc
Abata Therapeutics
Abcuro Inc
Alzheon Inc
Cleave Therapeutics Inc
Leadiant Biosciences Inc
Milo Biotechnology LLC
Nobelpharma Co Ltd
PhaseBio Pharmaceuticals Inc
Vandria SA